Successful Treatment with Atomoxetine of an Adolescent Boy with Attention Deficit/Hyperactivity Disorder, Extreme Obesity, and Reduced Melanocortin 4 Receptor Function

Successful Treatment with Atomoxetine of an Adolescent Boy with Attention Deficit/Hyperactivity Disorder, Extreme Obesity, and Reduced Melanocortin 4 Receptor Function

Objective: Recent case reports suggest a link between reduced melanocortinergic tone and both obesity and attention deficit / hyperactivity disorder (ADHD). We present the case of a 13-year-old, male, obese MC4R mutation carrier with ADHD. Case Report: The boy carries a heterozygous mutation in the...

Full description

Bibliographic Details
Main Authors: Wilfried Pott, Özgür Albayrak, Anke Hinney, Johannes Hebebrand, Ursula Pauli-Pott
Format: Article
Language:English
Published: Karger Publishers 2013-03-01
Series:Obesity Facts
Subjects:
Methylphenidate
Pharmacogenetics
Brain-derived neurotrophic factor
Weight loss
Appetite control
Online Access:http://www.karger.com/Article/FullText/348792

Internet

http://www.karger.com/Article/FullText/348792

Similar Items